CareStart™ Dengue RDT
Access Bio
Solution Overview & Benefits
Dengue virus is transmitted by mosquitoes, and more than one-third of the world’s population is at risk for infection. Because there are no vaccines available to prevent infection of dengue virus, early diagnosis and prompt supportive treatment can substantially lower the risk of death and medical complications.
IgM/IgG: 20 μl/10 μl/10μl
History & Development
A healthy life, free of illness, is a long-held wish in society. Guided by the basic principles of cherishing life and health for all people, Access Bio has been dedicated to the research, development and quality improvement of the medical diagnosis industry. Through the development of in vitro diagnostics technology, Access Bio has successfully commercialized products of outstanding quality to battle malaria and other diseases that pose a serious health threat across the globe.
Availability
- Publicly available: Yes
- Countries where available: Not for sale in the USA
- Price range: Contact supplier for quote
- Offered or can be licensed for local manufacture: No
Similar solutions...
Get in Touch!
Get in touch with us by filling out the form or emailing us at contact@techxlab.org.
